Endothelial progenitor cell-seeded grafts: Rash and risky

Canadian Journal of Cardiology

Volumn 22, Issue 13, 2006, Pages 1113-1116

  Rotmans, Joris I ^a   Heyligers, Jan M M ^b   Stroes, Erik S G ^a   Pasterkamp, Gerard ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Endothelial progenitor cells; Intimal hyperplasia; Prosthetic graft seeding

Indexed keywords

ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL GRAFT; BYPASS SURGERY; CD34 SELECTION; ENDOTHELIUM CELL; GRAFT PATENCY; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; MACROPHAGE; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; RISK ASSESSMENT; SMOOTH MUSCLE FIBER; THROMBOCYTE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASCULAR PATENCY; VASCULAR SMOOTH MUSCLE;

EID: 33845578537     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(06)70946-1     Document Type: Article

References (16)

1. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-61.
2. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004;27:357-62.
3. Schwab SJ, Harrington JT, Singh A, et al. Vascular access for hemodialysis. Kidney Int 1999;55:2078-90.
4. USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2002.
5. Rotmans JI, Pasterkamp G, Verhagen HJ, Pattynama PM, Btankestijn PJ, Stroes ES. Hemodialysis access graft failure: Time to revisit an unmet clinical need? J Nephrol 2005;18:9,20.
6. Herring M, Gardner A, Glover J. A singte-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978;84:498-504.
7. Deutsch M, Meinhart J, Fischlein T, Preiss P, Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: A 9-year experience. Surgery 1999;126:847-55.
8. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
9. Bhattacharya V, McSweeney PA, Shi Q, et al. Enhanced endotheliatization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000;95:581-5.
10. Griese DF, Ehsan A, Melo LG, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: Implications for cell-based vascular therapy. Circulation 2003;108:2710-5.
11. Rotmans JI, Heyligers JM, Verhagen HJ, et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates enclothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005;112:12-8.
12. Rotmans JI, Velema E, Verhagen HJ, et al. Rapid, arteriovenous graft failure due to intimal hyperplasia: A porcine, bilateral, carotid arteriovenous graft model. J Surg Res 2003;113:161-71.
13. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403-9.
14. Hill JM, Zalos G, Halcox JP. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
15. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105:3017-24.
16. Harraz M, Jiao C, Hanlon HID, Hartley RS, Schatteman GC. CD34-blood-derived human endothelial cell progenitors. Stem Cells 2001;19:304-12.